Cost-effectiveness of influenza vaccination in high-risk children in Argentina
- PMID: 11457546
- DOI: 10.1016/s0264-410x(01)00160-8
Cost-effectiveness of influenza vaccination in high-risk children in Argentina
Abstract
Objectives: our study aimed to evaluate the cost-effectiveness of influenza vaccination in high-risk children in Argentina.
Methods: a decision analysis model was performed, using data from published and unpublished sources, to compare two strategies--to vaccinate or not to vaccinate. We simulated the expected consequences of vaccination on direct medical costs, related to disease management and indirect costs, related to lost parental working days (absenteeism).
Results: Using base-case assumptions vaccination of high-risk children aged 6 months to 15 years old, in Argentina (estimated cohort of 1184748) would prevent 207331 cases of influenza, resulting in a reduction of 58052 days of hospitalization and 207331 outpatient visits. Vaccination would lead to net savings of US$ 11894870 per vaccinated cohort (US$ 10.04 per vaccinated child).
Conclusion: our economic analysis shows that in Argentina, routine vaccination of high-risk children against influenza would be cost saving for society.
Similar articles
-
Public health and economic benefits of new pediatric influenza vaccination programs in Argentina.Hum Vaccin Immunother. 2012 Mar;8(3):312-22. doi: 10.4161/hv.18569. Epub 2012 Feb 14. Hum Vaccin Immunother. 2012. PMID: 22330959 Free PMC article.
-
Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.Vaccine. 2011 Oct 6;29(43):7554-8. doi: 10.1016/j.vaccine.2011.08.015. Epub 2011 Aug 4. Vaccine. 2011. PMID: 21820477 Review.
-
Cost-effectiveness of influenza vaccination of healthy children.Vaccine. 2006 Jun 5;24(23):4934-41. doi: 10.1016/j.vaccine.2006.03.057. Epub 2006 Apr 7. Vaccine. 2006. PMID: 16678945
-
Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.Arch Intern Med. 2001 Mar 12;161(5):749-59. doi: 10.1001/archinte.161.5.749. Arch Intern Med. 2001. PMID: 11231710
-
A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.PLoS One. 2018 Jun 7;13(6):e0198685. doi: 10.1371/journal.pone.0198685. eCollection 2018. PLoS One. 2018. PMID: 29879206 Free PMC article.
Cited by
-
Economic impact of a rotavirus vaccine in Brazil.J Health Popul Nutr. 2008 Dec;26(4):388-96. doi: 10.3329/jhpn.v26i4.1880. J Health Popul Nutr. 2008. PMID: 19069617 Free PMC article.
-
Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.Hum Vaccin Immunother. 2013 Mar;9(3):707-11. doi: 10.4161/hv.23269. Epub 2013 Jan 7. Hum Vaccin Immunother. 2013. PMID: 23295894 Free PMC article.
-
Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review.Vaccines (Basel). 2021 Feb 2;9(2):111. doi: 10.3390/vaccines9020111. Vaccines (Basel). 2021. PMID: 33540633 Free PMC article. Review.
-
Public health and economic benefits of new pediatric influenza vaccination programs in Argentina.Hum Vaccin Immunother. 2012 Mar;8(3):312-22. doi: 10.4161/hv.18569. Epub 2012 Feb 14. Hum Vaccin Immunother. 2012. PMID: 22330959 Free PMC article.
-
Influenza virus surveillance in Argentina during the 2012 season: antigenic characterization, genetic analysis and antiviral susceptibility.Epidemiol Infect. 2016 Mar;144(4):751-67. doi: 10.1017/S0950268815001806. Epub 2015 Sep 8. Epidemiol Infect. 2016. PMID: 26345289 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical